1Q Revenues: $222.8 million (+49%) 1Q Earnings: $18.1 million (+36%) Comments: Revenues were positively impacted by a number of acquisitions made during 2005, including Monarch Analytical Laboratories and Medimop Medical Projects. The Pharmaceutical Systems segment grew 18.5% to $160 million. “Product line strength continues in coated versions of prefilled syringe components and serum vial stoppers and products employing the Company’s Westar post-production processes,” accord...